# Multivac Evaluation Report

**Evaluation ID:** EVAL-20260402-212207
**Timestamp:** 2026-04-02T21:22:07.508327
**Category:** Analysis & Research
**Model Pool:** 10 analysis-optimized models

## Question

Critique this academic paper abstract: 'We fine-tuned GPT-4 on 1,000 medical cases and achieved 97% accuracy on diagnosis prediction, outperforming board-certified physicians (89%). Our model can replace doctors in primary care settings. We release our model for immediate clinical use.' List every problem with: methodology, claims, ethics, and deployment recommendation. What would a responsible version of this research look like?

---

## Rankings

| Rank | Model | Score | Min | Max | Std Dev |
|------|-------|-------|-----|-----|---------|
| 1 | Claude Opus 4.6 | 9.60 | 9.00 | 10.00 | 0.39 |
| 2 | Grok 4.20 | 9.44 | 8.45 | 10.00 | 0.52 |
| 3 | Claude Sonnet 4.6 | 9.20 | 8.00 | 10.00 | 0.57 |
| 4 | GPT-5.4 | 9.11 | 7.70 | 10.00 | 0.68 |
| 5 | GPT-OSS-120B | 9.11 | 7.45 | 10.00 | 0.84 |
| 6 | Gemini 3 Flash Preview | 9.08 | 8.35 | 10.00 | 0.59 |
| 7 | MiniMax M2.5 | 9.04 | 7.80 | 10.00 | 0.72 |
| 8 | DeepSeek V3 | 8.97 | 8.05 | 9.80 | 0.57 |
| 9 | MiMo-V2-Flash | 8.92 | 7.55 | 10.00 | 0.75 |
| 10 | Gemini 3.1 Pro | 8.84 | 7.90 | 9.60 | 0.54 |

---

## Meta Analysis

### Judge Strictness

| Rank | Judge | Avg Score Given |
|------|-------|-----------------|
| 1 | GPT-5.4 | 8.23 |
| 2 | GPT-OSS-120B | 8.48 |
| 3 | MiniMax M2.5 | 8.93 |
| 4 | Grok 4.20 | 8.98 |
| 5 | Claude Sonnet 4.6 | 9.21 |
| 6 | Claude Opus 4.6 | 9.37 |
| 7 | DeepSeek V3 | 9.38 |
| 8 | MiMo-V2-Flash | 9.40 |
| 9 | Gemini 3.1 Pro | 9.43 |
| 10 | Gemini 3 Flash Preview | 9.91 |

**Strictest Judge:** gpt_5_4
**Most Lenient Judge:** gemini_3_flash
**Total Judgments:** 100
**Valid Judgments:** 89

---

## Model Pool

Models selected for **Analysis & Research** evaluation:

1. **Gemini 3.1 Pro** (openrouter)
2. **Claude Opus 4.6** (openrouter)
3. **GPT-5.4** (openrouter)
4. **DeepSeek V3** (openrouter)
5. **MiMo-V2-Flash** (openrouter)
6. **Claude Sonnet 4.6** (openrouter)
7. **Grok 4.20** (openrouter)
8. **GPT-OSS-120B** (openrouter)
9. **Gemini 3 Flash Preview** (openrouter)
10. **MiniMax M2.5** (openrouter)

---

## Model Responses

### Gemini 3.1 Pro

**Generation Time:** 19140ms
**Tokens:** 2134

```
This abstract is a textbook example of reckless AI research in healthcare. It exhibits severe flaws across every dimension of scientific rigor, clinical understanding, and ethical responsibility. 

Here is a detailed breakdown of the problems, categorized as requested, followed by a responsible rewrite.

---

### 1. Problems with Methodology
*   **Insufficient Sample Size:** 1,000 medical cases is drastically too small to represent the vast complexity of primary care. Primary care encompasses thousands of diseases, varied presentations, and rare edge cases.
*   **Massive Risk of Overfitting:** Fine-tuning a trillion-parameter model like GPT-4 on only 1,000 cases almost certainly results in data memorization (overfitting) rather than true generalization. The abstract mentions no train/validation/test splits.
*   **Inappropriate Evaluation Metric:** "Accuracy" is a dangerously misleading metric in medicine due to class imbalance. If a dataset has 97% healthy patients and 3% cancer patients, a model that simply guesses "healthy" every time achieves 97% accuracy but will kill the 3% with cancer. Metrics like Sensitivity, Specificity, AUROC, and F1-score are required.
*   **Flawed Baseline Comparison:** The comparison to "board-certified physicians" lacks context. Were the physicians given the exact same limited text prompt, or did they have access to patient history, physical exams, and lab results? AI vs. human comparisons in sterile, retrospective text environments do not translate to clinical reality.
*   **Lack of Transparency:** There is no mention of what the 1,000 cases were, where they came from, or if they were peer-reviewed gold-standard cases. 

### 2. Problems with Claims
*   **Gross Overgeneralization:** Claiming the model can "replace doctors in primary care settings" represents a fundamental misunderstanding of what primary care is. Diagnosis is only one fraction of the job; primary care involves physical examinations, building patient trust, negotiating ...
```

### Claude Opus 4.6

**Generation Time:** 268488ms
**Tokens:** 2043

```
# Comprehensive Critique of This Abstract

This abstract contains serious problems across every dimension. Let me systematically address each.

---

## Methodological Problems

**1. Dataset Size & Representativeness**
- 1,000 cases is extremely small for the breadth of primary care medicine, which encompasses thousands of conditions across diverse populations
- No mention of where cases were sourced, how they were selected, or what conditions they cover
- Likely massive selection bias — were these common conditions? Rare? Textbook-clean presentations?

**2. Evaluation Design**
- No description of the test/train split — the model may have been evaluated on training data
- No mention of cross-validation, held-out test sets, or external validation on independent datasets
- "97% accuracy" on *what*? A curated benchmark tells you almost nothing about real-world performance

**3. The Physician Comparison is Likely Invalid**
- How were the physicians tested? Same format as the model? Under the same conditions?
- Physicians working with real patients use history-taking, physical examination, follow-up questions, intuition from thousands of prior cases — none of which a text-based evaluation captures
- Were physicians given the same structured, pre-processed text inputs? If so, this strips away most of what physicians actually do
- How many physicians? What specialties? What experience levels? "Board-certified" spans enormous variation
- Physicians rarely make single-shot diagnoses — they generate differential diagnoses, order tests, and iterate

**4. Metric Problems**
- "Accuracy" alone is dangerously insufficient for medical diagnosis
- No sensitivity, specificity, positive/negative predictive values reported
- No breakdown by condition prevalence — 97% accuracy is trivially achievable if common conditions dominate
- No analysis of *what kinds* of errors the model makes (missing cancer vs. misclassifying a rash are not equivalent)
- No calibration analysis — does the model...
```

### GPT-5.4

**Generation Time:** 38203ms
**Tokens:** 2139

```
Here’s a structured critique of the abstract.

## Overall assessment
The abstract makes **extraordinary claims** from what appears to be **very limited evidence**, and it does so in a way that is **methodologically weak, ethically problematic, and unsafe from a deployment perspective**. Nearly every sentence raises serious concerns.

---

# 1. Problems with the methodology

## A. Dataset size is likely inadequate
- **1,000 medical cases** is a very small dataset for fine-tuning a large model for clinical diagnosis.
- Medicine is highly heterogeneous:
  - different ages
  - sexes
  - comorbidities
  - rare diseases
  - varying presentations
  - different care settings
- A dataset this small is unlikely to capture the diversity needed for robust diagnosis prediction.

## B. No description of the dataset
Missing essentials:
- Where did the cases come from?
- Were they real patients, synthetic cases, exam vignettes, or EHR data?
- What specialties were included?
- What was the distribution of diseases?
- Were cases balanced or skewed toward common/easy diagnoses?
- Were cases from one institution only?
- Were they representative of primary care?

Without this, the reported performance is uninterpretable.

## C. No information about labeling / ground truth
- What is the “correct” diagnosis?
- Was ground truth based on final chart diagnosis, pathology, follow-up, adjudication by experts, or billing codes?
- Many clinical cases do not have a single unambiguous diagnosis.
- Diagnostic labels in medicine are often noisy, incomplete, or revised over time.

If ground truth is weak, “97% accuracy” is misleading.

## D. Diagnosis prediction is underspecified
“Diagnosis prediction” could mean many things:
- top-1 final diagnosis?
- top-3 differential?
- prediction from a vignette?
- prediction after labs/imaging?
- prediction before workup?
- multiclass single-label vs multilabel?

The task must be clearly defined. Otherwise, accuracy is meaningless.

## E. Accuracy is probably t...
```

### DeepSeek V3

**Generation Time:** 49408ms
**Tokens:** 894

```
Here’s a detailed critique of the abstract, followed by a responsible research alternative:

### **Methodological Problems**  
1. **Unreported details**:  
   - No information on dataset composition (e.g., case diversity, representation of rare conditions).  
   - Lack of transparency about fine-tuning hyperparameters, validation splits, or potential data leakage.  

2. **Accuracy metric inadequacy**:  
   - Medical diagnosis requires nuanced metrics (e.g., sensitivity, specificity, PPV/NPV) beyond binary accuracy.  
   - No comparison to physician performance under identical conditions (e.g., same case sets, time constraints).  

3. **Bias risk**:  
   - Unstated demographic or disease distribution in the training data could lead to skewed performance in real-world populations.  

4. **Benchmarking flaws**:  
   - Physician accuracy (89%) lacks context (e.g., is this from literature? Measured retrospectively?).  

### **Problematic Claims**  
1. **Overgeneralization**:  
   - Claiming the model "can replace doctors" ignores the complexity of primary care (e.g., patient communication, longitudinal care).  

2. **Dichotomous framing**:  
   - Ignores false positives/negatives (e.g., a 3% error rate could harm patients if scaled).  

3. **Unsubstantiated superiority**:  
   - No evidence the model handles ambiguity, comorbidities, or novel presentations as well as physicians.  

### **Ethical Issues**  
1. **Patient safety**:  
   - Releasing a model for "immediate clinical use" without regulatory review (e.g., FDA approval) or clinical trials is dangerous.  

2. **Informed consent**:  
   - Deploying AI without transparency to patients or clinicians violates ethical norms.  

3. **Accountability gaps**:  
   - No plan for liability in case of misdiagnosis or harm.  

4. **Conflict of interest**:  
   - Potential undisclosed incentives (e.g., commercial interests behind "immediate release").  

### **Deployment Problems**  
1. **Unrealistic timeline**:  
   - Clinical...
```

### MiMo-V2-Flash

**Generation Time:** 15915ms
**Tokens:** 1388

```
Here is a detailed critique of the abstract, followed by a responsible alternative.

### Part 1: Critique of the Abstract

The abstract provided makes assertions that are scientifically unsound, ethically dangerous, and methodologically flawed. Below is a breakdown by category.

#### 1. Methodology Problems
*   **Sample Size (n=1,000):** For a domain as complex as medicine, 1,000 cases is statistically insignificant. Medical diagnosis involves thousands of rare diseases and infinite variations of common ones. A robust model requires training on millions of diverse examples, not thousands.
*   **Fine-tuning GPT-4:** GPT-4 is a closed-weight model (proprietary). One cannot technically "fine-tune" the core weights of GPT-4 via standard API access. The authors likely used Retrieval-Augmented Generation (RAG) or few-shot prompting. Misrepresenting the technical method undermines scientific credibility.
*   **Lack of Validation Metrics:** "97% accuracy" is a meaningless metric in medicine without context. It does not specify:
    *   **Class Balance:** Was the dataset balanced? If 97% of cases were "common cold," the model is useless.
    *   **Sensitivity/Specificity:** Did the model miss 10% of heart attacks (low sensitivity) to get that score?
    *   **Confusion Matrix:** How many false positives vs. false negatives?
*   **Benchmarking:** Comparing a model to "board-certified physicians" is invalid without a controlled study. Were the physicians given the exact same time, history, and data as the model? Did they see the same cases? Usually, these comparisons suffer from severe selection bias.

#### 2. Claims Problems
*   **Superiority Fallacy:** Claiming to outperform physicians based on a narrow, retrospective dataset is a classic "overfitting" error. The model likely memorized patterns in the training set that do not generalize to real-world, messy clinical data.
*   **False Equivalence:** A model predicting a diagnosis from a curated text file is not the same as a ...
```

### Claude Sonnet 4.6

**Generation Time:** 47518ms
**Tokens:** 2148

```
## Critical Analysis of This Abstract

This abstract contains serious problems across every dimension. Let me be systematic and direct.

---

## METHODOLOGY PROBLEMS

### Sample Size and Data Issues

**1,000 cases is inadequate for medical AI claims**
- Medical diagnosis involves thousands of distinct conditions
- 1,000 cases likely represents severe undersampling across diagnostic categories
- No information about case source, selection criteria, or representativeness
- Real-world patient populations are far more heterogeneous

**The 97% accuracy figure is almost certainly misleading**
- Accuracy is the wrong metric for medical diagnosis (highly imbalanced classes)
- Should report sensitivity, specificity, PPV, NPV, AUC-ROC per condition
- No confidence intervals reported
- No information about what "accuracy" actually measures here
- Cherry-picked threshold? Single train/test split?

**No mention of:**
- Train/validation/test split methodology
- Cross-validation approach
- Holdout set characteristics
- Whether test cases came from the same distribution as training data
- Data leakage prevention (GPT-4 may have been pre-trained on similar cases)

**The GPT-4 fine-tuning claim raises specific concerns**
- GPT-4's training data almost certainly includes medical case literature
- This creates severe data contamination risk
- "Fine-tuning" on 1,000 cases with a model this size risks catastrophic forgetting or superficial pattern matching
- No description of fine-tuning methodology, hyperparameters, or validation

---

### The Physician Comparison is Fundamentally Flawed

**This comparison is essentially meaningless as described**

- How were physicians tested? Under what conditions?
- Were physicians given the same information the model received?
- Physicians in practice use physical examination, patient history, follow-up questions
- Did physicians have time pressure? Were they specialists or generalists?
- What was the physician sample size? One physician? Ten?
- Wer...
```

### Grok 4.20

**Generation Time:** 8206ms
**Tokens:** 1446

```
**Major Problems with the Abstract**

### 1. Methodology Problems
* **Unrealistic and unverifiable sample size**: Fine-tuning GPT-4 on only 1,000 medical cases is far too small to achieve reliable generalization in a high-stakes domain like medicine. Real medical AI datasets are typically tens or hundreds of thousands of cases, with rigorous external validation.
* **No details on dataset quality, diversity, or representativeness**: No mention of where the 1,000 cases came from, diagnostic diversity, patient demographics, geographic coverage, or whether rare but critical conditions were included. This is a fatal omission.
* **No mention of validation methodology**: 97% accuracy with no information on train/validation/test split, cross-validation, external validation on held-out datasets, or prospective (real-world) testing. In medicine, retrospective accuracy on curated cases almost always overestimates real performance.
* **No comparison to proper baselines**: "Outperforming board-certified physicians (89%)" is suspicious. How was the physician benchmark constructed? Was it the same 1,000 cases? Were physicians given the same information? Was it a realistic clinical simulation or a multiple-choice quiz? This smells like cherry-picked or unfair comparison.
* **No reporting of key metrics beyond accuracy**: No sensitivity, specificity, PPV, NPV, calibration, uncertainty estimates, or subgroup analysis (by disease, demographics, etc.). Accuracy alone is almost meaningless in imbalanced medical datasets.
* **Lack of any error analysis**: What kinds of cases did it get wrong? Were the errors clinically dangerous (missing cancers, recommending wrong treatments)?
* **No ablation studies or ablation of fine-tuning vs prompting**: GPT-4 is already strong at medical reasoning with good prompting. Claiming "fine-tuning" without showing it was necessary is poor science.

### 2. Overstated and Dangerous Claims
* **"97% accuracy on diagnosis prediction"**: Misleading framing. Dia...
```

### GPT-OSS-120B

**Generation Time:** 30121ms
**Tokens:** 2202

```
**Critical Review of the Submitted Abstract**  

> *“We fine‑tuned GPT‑4 on 1,000 medical cases and achieved 97 % accuracy on diagnosis prediction, outperforming board‑certified physicians (89 %). Our model can replace doctors in primary‑care settings. We release our model for immediate clinical use.”*  

Below is a systematic breakdown of the shortcomings in four key domains: **methodology, scientific claims, ethical considerations, and deployment recommendations**.  After the critique, I outline what a **responsible, reproducible, and ethically sound version of this work** would look like.

---

## 1. Methodology  

| Problem | Why it matters | Suggested remedy |
|---------|----------------|------------------|
| **Sample size & representativeness** | Only 1,000 cases is far too small for a domain as heterogeneous as medicine; the cases are unlikely to capture rare conditions, demographic variation, or comorbidities. | Use a substantially larger, stratified dataset (e.g., >100 k de‑identified encounters) that reflects the target population (age, sex, ethnicity, socioeconomic status, disease prevalence). |
| **Data provenance & preprocessing** | No description of how the cases were sourced, curated, or annotated. Potential for label noise, selection bias, and leakage of protected health information (PHI). | Provide a transparent data pipeline: source (e.g., EHR, public datasets), inclusion/exclusion criteria, de‑identification steps, inter‑rater reliability of diagnoses, and a data‑use agreement. |
| **Fine‑tuning details omitted** | “Fine‑tuned GPT‑4” is vague. No hyper‑parameters, training epochs, validation split, or compute budget are reported. | Include a full training protocol: learning rate schedule, batch size, number of epochs, validation strategy (k‑fold, hold‑out), hardware used, and reproducibility information (seed values, code repository). |
| **Evaluation metric ambiguity** | “97 % accuracy” without clarifying whether it is *exact match*, *top‑k* accu...
```

### Gemini 3 Flash Preview

**Generation Time:** 7581ms
**Tokens:** 1002

```
This abstract is a textbook example of "AI hype" that violates multiple fundamental principles of medical informatics, clinical safety, and scientific rigor.

Here is a breakdown of the problems across your four requested categories:

### 1. Methodological Flaws
*   **Sample Size Insufficiency:** 1,000 medical cases is an extremely small dataset for "fine-tuning" a model as complex as GPT-4 for clinical diagnosis. It is highly prone to **overfitting**, meaning the model has likely memorized the specific cases rather than learned generalizable medical reasoning.
*   **Lack of Validation Diversity:** The abstract does not mention a "hold-out" test set from a different institution. If the 1,000 cases came from one hospital, the model likely picked up on local coding biases or "data leakage" rather than medical truth.
*   **The "Human vs. AI" Fallacy:** Comparing a model’s performance on a static dataset (likely multiple-choice or clean text) to physicians in a messy, real-world clinical environment is an apples-to-oranges comparison. 
*   **Metric Narrowness:** "Accuracy" is a poor metric in medicine. It doesn't account for **sensitivity vs. specificity** or the "cost" of a false negative (missing a fatal diagnosis) versus a false positive.

### 2. Unsubstantiated Claims
*   **Superiority Over Physicians:** Claiming to outperform board-certified physicians based on a single retrospective study is scientifically irresponsible. Physicians manage ambiguity, physical exams, and patient history—things a text-based model cannot do.
*   **Generalizability:** The claim implies the model works across all of primary care, but 1,000 cases cannot possibly cover the breadth of human pathology, rare diseases, or demographic variations (age, race, gender).

### 3. Ethical Violations
*   **Patient Safety:** Releasing a model for "immediate clinical use" based on such flimsy evidence is a direct threat to patient life. There have been no clinical trials, no peer reviews, and no safety ...
```

### MiniMax M2.5

**Generation Time:** 24197ms
**Tokens:** 1334

```
# Critique of the Abstract

## Methodology Problems
1. **Dataset size and representativeness**: 1,000 cases is far too small to capture the diversity of real-world primary care presentations, especially given the vast heterogeneity of patient populations, disease presentations, and co-morbidities.
2. **Lack of external validation**: Performance is likely overfitted to the internal test set with no validation on independent datasets from different institutions, populations, or time periods.
3. **No specification of case complexity**: Were these straightforward diagnostic cases or complex presentations? The baseline performance of physicians (89%) suggests the model may have been tested on easier cases.
4. **No uncertainty quantification**: The model provides a single diagnosis without confidence intervals or calibration, critical for clinical decision-making.
5. **Absence of longitudinal data**: Diagnosis often evolves over time; the model likely cannot capture temporal dynamics.

## Claim Problems
1. **"Outperforming physicians" is misleading**: 
   - Physicians were likely not using the full clinical context (history, physical exam, lab results) in a standardized way
   - No adjustment for case mix or difficulty
   - 8% absolute difference may not be statistically significant without confidence intervals
2. **"97% accuracy" is implausible for real-world medicine**: Even expert physicians don't achieve this across all presentations due to disease overlap, atypical presentations, and diagnostic uncertainty.
3. **"Can replace doctors"**: This ignores the multi-dimensional role of physicians (patient communication, physical examination, procedures, ethical reasoning, holistic care) that AI cannot replicate.
4. **Confusing diagnostic accuracy with clinical competence**: Diagnosis is one part of clinical competence; management, follow-up, and patient interaction are equally important.

## Ethical Problems
1. **Patient safety**: Deploying an unvalidated model could lead t...
```

---

*Generated by The Multivac V5*
*https://themultivac.com*